Scarica l'app Stockscreener
63.47
15.02%
8.29
Pre-mercato:
64.10
0.63
+0.99%
Precedente Chiudi:
$55.18
Aprire:
$55.23
Volume 24 ore:
31.39M
Relative Volume:
2.53
Capitalizzazione di mercato:
$10.67B
Reddito:
$803.32M
Utile/perdita netta:
$-709.10M
Rapporto P/E:
-8.1369
EPS:
-7.8003
Flusso di cassa netto:
$-212.68M
1 W Prestazione:
+1.45%
1M Prestazione:
+11.23%
6M Prestazione:
+0.84%
1 anno Prestazione:
+0.00%
Intervallo 1D:
$55.12
$65.35
Intervallo di 1 settimana:
$52.55
$68.75
Portata 52W:
$22.89
$91.45
Tempus Ai Inc Stock (TEM) Company Profile
Nome
Tempus Ai Inc
Settore
Industria
Telefono
800-976-5448
Indirizzo
600 WEST CHICAGO AVENUE, CHICAGO
Confronta TEM con altri titoli
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
TEM
Tempus Ai Inc
|
63.47 | 11.40B | 803.32M | -709.10M | -212.68M | -7.8003 |
|
VEEV
Veeva Systems Inc
|
278.63 | 38.79B | 2.86B | 780.66M | 1.20B | 4.72 |
|
HQY
Healthequity Inc
|
102.81 | 8.76B | 1.15B | 96.70M | -161.99M | 1.09 |
|
DOCS
Doximity Inc
|
51.50 | 9.79B | 550.17M | 201.35M | 232.07M | 1.00 |
|
WAY
Waystar Holding Corp
|
39.77 | 6.77B | 906.14M | -52.62M | 89.62M | -0.3621 |
Tempus Ai Inc Stock (TEM) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2025-04-21 | Iniziato | BTIG Research | Buy |
| 2025-02-25 | Downgrade | JP Morgan | Overweight → Neutral |
| 2025-02-12 | Downgrade | William Blair | Outperform → Mkt Perform |
| 2025-02-05 | Ripresa | TD Cowen | Buy |
| 2024-12-13 | Iniziato | Wolfe Research | Outperform |
| 2024-12-09 | Iniziato | Guggenheim | Buy |
| 2024-11-11 | Downgrade | Stifel | Buy → Hold |
| 2024-10-02 | Downgrade | BofA Securities | Buy → Neutral |
| 2024-08-12 | Iniziato | Piper Sandler | Neutral |
| 2024-07-09 | Iniziato | BofA Securities | Buy |
| 2024-07-09 | Iniziato | JP Morgan | Overweight |
| 2024-07-09 | Iniziato | Longbow | Buy |
| 2024-07-09 | Iniziato | Loop Capital | Buy |
| 2024-07-09 | Iniziato | Morgan Stanley | Overweight |
| 2024-07-09 | Iniziato | Needham | Buy |
| 2024-07-09 | Iniziato | Stifel | Buy |
| 2024-07-09 | Iniziato | TD Cowen | Buy |
| 2024-07-09 | Iniziato | William Blair | Outperform |
Mostra tutto
Tempus Ai Inc Borsa (TEM) Ultime notizie
Why Tempus AI, Inc. (TEM) Skyrocketed On Monday - Insider Monkey
James J. Burns & Company LLC Raises Position in Tempus AI, Inc. (NASDAQ:TEM) - MarketBeat
ProShare Advisors LLC Takes $244,000 Position in Tempus AI, Inc. (NASDAQ:TEM) - MarketBeat
Why Tempus AI Stock Soared 15% Today - AOL.com
Tempus AI Unveils New Liquid Biopsy Assay for Early Immunotherapy Response Monitoring in Cancer - Insider Monkey
Tempus AI recovers 15% as Wall Street downplays Spruce Point allegations - Investing.com Australia
Tempus AI Expands Tempus One with EHR Integration, New AI Features - Insider Monkey
Tempus AI Sees Unusually Large Options Volume (NASDAQ:TEM) - MarketBeat
Tempus AI recovers after TD Cowen criticizes short report - Seeking Alpha
Tempus AI (NASDAQ:TEM) Stock Price Up 13.9%Still a Buy? - MarketBeat
Tempus AI rebound, Meta's AI ad push, Broadcom earnings optimism - Yahoo Finance
Tempus AI (NASDAQ:TEM) Sees Strong Trading VolumeHere's Why - MarketBeat
TD Cowen maintains buy rating on Tempus AI stock after short report - Investing.com Canada
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Tempus AI, Inc.TEM - FinancialContent
TEM Investor News: If You Have Suffered Losses in Tempus AI, Inc. (NASDAQ: TEM), You Are ... - Eagle-Tribune
TEM Investor News: If You Have Suffered Losses in Tempus AI, Inc. (NASDAQ: TEM), You Are Encouraged to Contact The Rosen Law Firm About Your Rights - TradingView
Tempus AI Stock Rockets After Introduction Of Liquid Biopsy Assay For Cancer Treatment Monitoring: Retail Hopes For A 20% Rally - Asianet Newsable
Tempus AI jumps after hit from short seller’s report - Sherwood News
Tempus AI, Inc. Class A Stocks Surge Amid Market Buzz - TipRanks
Tempus AI (TEM) Stock Skyrockets Over 13% on Strong Investor Demand - Daily Chhattisgarh News
Tempus AI (TEM) Stock Surges Over 13% on Nasdaq, Trades Above $62 - Daily Chhattisgarh News
Tempus AI, Inc. (NASDAQ:TEM) Given Average Recommendation of "Moderate Buy" by Analysts - MarketBeat
Lost Investment in Tempus AI, Inc. (TEM)? Levi & Korsinsky Launches Securities Fraud Investigation - ACCESS Newswire
Tempus AI unveils liquid biopsy for cancer treatment monitoring - Investing.com
Tempus Introduces xM, An Assay To Monitor Immunotherapy Response For Patients With Advanced Cancers - marketscreener.com
Tempus Introduces xM, An Assay to Monitor Immunotherapy Response for Patients with Advanced Cancers - Eagle-Tribune
Tempus Announces 10 Abstracts Accepted for Presentation at the 2025 American Society of Clinical Oncology Annual Meeting - marketscreener.com
Bank of America Corp DE Lowers Position in Tempus AI, Inc. (NASDAQ:TEM) - MarketBeat
Tempus AI announces launch of its Fuses program - TipRanks
Fraud Investigation Opened: Levi & Korsinsky Investigates Tempus AI, Inc. (TEM) on Behalf of Shareholders - ACCESS Newswire
Cathie Wood buys $13.9 million of popular AI stock - TheStreet
Introducing Tempus One in the EHR with Integrated Guidelines - 01net
Bronstein, Gewirtz & Grossman, LLC Announces an Investigation Against Tempus AI, Inc. (TEM) and Encourages Stockholders to Learn More About the Investigation - ACCESS Newswire
Pomerantz Law Firm Investigates Claims On Behalf of Investors of Tempus AI, Inc.TEM - marketscreener.com
Tempus AI, Inc. (NASDAQ:TEM) is Green Alpha Advisors LLC's 9th Largest Position - MarketBeat
ProShare Advisors LLC Buys Shares of 7,220 Tempus AI, Inc. (NASDAQ:TEM) - Defense World
Tempus AI (NASDAQ:TEM) Shares Up 2.7%Here's Why - MarketBeat
Tempus AI (NASDAQ:TEM) Trading Down 15.1%Here's Why - MarketBeat
Tempus AI, Inc. (TEM) Launches ‘Fuses’ to Power AI-Driven Precision Diagnostics - Insider Monkey
TEM ALERT: Ongoing Investigation Into Tempus AI, Inc.Contact Levi & Korsinsky - ACCESS Newswire
Tempus AI hits back at scathing short report - Yahoo Finance
Tempus Introduces Fuses, A Program Designed to Transform Therapeutic Research and Build the Largest Diagnostic Platform Using its Novel Foundation Model - 01net
Tempus AI announces 10 abstracts accepted for presentation at 2025 ASCO meeting - Yahoo Finance
Tempus Introduces Fuses, A Program Designed To Transform Therapeutic Research And Build The Largest Diagnostic Platform Using Its Novel Foundation Model - marketscreener.com
Healthcare Stocks To Keep An Eye On – May 29th - Defense World
Tempus AI (NASDAQ:TEM) Shares Gap DownShould You Sell? - MarketBeat
Top Medical Stocks To Watch Now – May 29th - Defense World
Voloridge Investment Management LLC Invests $11.83 Million in Tempus AI, Inc. (NASDAQ:TEM) - MarketBeat
TEM ALERT: Levi & Korsinsky Investigates Tempus AI, Inc. on Behalf of Shareholders Who Lost Money - ACCESS Newswire
Potential Securities Fraud: Levi & Korsinsky Investigates Tempus AI, Inc. (TEM) - ACCESS Newswire
Levi & Korsinsky Investigates Tempus AI, Inc. (TEM) Over Potential Securities Fraud Allegations - ACCESS Newswire
Tempus Ai Inc Azioni (TEM) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
2.19%
1.13%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):